The JUP Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population derived from the HeLa cervical adenocarcinoma line, engineered for targeted disruption of the JUP gene. This product provides a loss-of-function model for plakoglobin, the protein encoded by JUP, within a human epithelial cancer background. The polyclonal format captures a heterogeneous spectrum of editing events, enabling robust analysis of gene function without the constraints of clonal selection. Researchers can employ this knockout model to explore plakoglobin??s roles in cell adhesion and signaling, utilizing a versatile tool suitable for a wide range of functional genomic and pharmacological studies.
HeLa cells constitute an HPV18-positive cervical adenocarcinoma line established in 1951, serving as a cornerstone of biomedical research. As adherent epithelial cells, they express integral components of cell?Ccell adhesion complexes and maintain active Wnt signaling pathways, making them an ideal host for investigating plakoglobin??s dual functions. The HeLa background offers well-characterized growth properties and extensive experimental precedent, facilitating integration into existing protocols for adhesion, migration, and transcription-based assays. This context is particularly relevant for cancer biology, as HeLa cells recapitulate features of transformed epithelial behavior and responsiveness to pathway perturbations.
Plakoglobin, a member of the catenin family, operates as a structural component of desmosomes and adherens junctions, linking cadherins such as E-cadherin to the cytoskeleton through interactions with desmoplakin, alpha-catenin, and beta-catenin. In the Wnt pathway, binding of Wnt3a to Frizzled receptors inhibits the Axin?CGSK3B?CAPC destruction complex, stabilizing plakoglobin and promoting its nuclear translocation. Nuclear plakoglobin partners with TCF7L2 and LEF1 transcription factors to regulate downstream targets, including CCND1, MYC, and AXIN2, thereby coordinating proliferative and adhesive programs. Consequently, JUP knockout disrupts both mechanical junction integrity and Wnt-dependent transcriptional outputs, offering a powerful system to dissect these interconnected processes.
Within HeLa cells, ablation of plakoglobin compromises desmosome and adherens junction assembly, leading to diminished cell?Ccell cohesion and altered migratory capacity. This perturbation is directly relevant to cancer metastasis, where loss of adhesion molecules facilitates tumor cell dissemination; JUP dysregulation has been associated with lung, colorectal, and ovarian carcinomas. Moreover, the knockout model enables mechanistic studies of arrhythmogenic right ventricular cardiomyopathy, a disease linked to desmosomal dysfunction and JUP mutations. By eliminating plakoglobin, researchers can assess its specific contributions to oncogenic phenotypes and Wnt-driven proliferation within a genetically tractable epithelial system.
This polyclonal knockout population supports a broad array of experimental approaches. Western blotting and immunofluorescence microscopy allow assessment of plakoglobin, cadherins, and junctional proteins, while cell aggregation and adhesion assays quantify intercellular cohesion. Wnt signaling activity can be monitored via TOP/FOP flash reporter assays, and transwell migration or invasion assays probe metastatic potential. Additional techniques include co-immunoprecipitation of desmosomal complexes, RT-qPCR for Wnt target genes, and transcriptomic profiling through RNA-seq. This product serves as a robust resource for investigations into cell adhesion, Wnt pathway dynamics, and cancer cell behavior. For further details or to discuss custom projects, please contact Ascent Research.
